Louisiana State University has selected its medical marijuana vendor and now LSU Health Shreveport is ready to prepare for Louisiana medical marijuana research.
On Sept. 8, 2017, the Louisiana State Board of Supervisors will meet to address several agenda items, including a proposal from LSU Health Shreveport to create the Center for Brain Health, which would research medical marijuana use for pharmacotherapeutic reasons and work with patients using medical marijuana, as well as conducting other innovative research to develop the latest therapies for brain injury and disease.
According to the Board of Supervisors’ agenda, “Year 1 funding includes $25K from the HSC-S Department of Neurology and $5K from the School of Allied Health, plus $15K from the Beaird Foundation and $1.2K from the Society for Neuroscience. Dr. Disbrow is currently working to secure an additional $55K from the Walmart Foundation. During the first year of the center, the director along with associated faculty and board members will continue to work on securing external funding through research grants, industry partnerships, and through collaborations with the other institutions directly involved in the collaboration.”
LSU Health Shreveport is only requesting a conditional one-year approval right now; however, following the first year, the center plans to submit a proposal to be fully approved.
On June 15, 2017, LSU announced its selection of GB Sciences (OTCQB:GBLX) to be its medical marijuana vendor, with the LSU Board of Supervisors approving the agreement on June 22.
On Aug. 29, the Louisiana Board of Pharmacy announced the solicitation of applications for medical marijuana pharmacy permits, of which there are 10 available.
Prospective pharmacies have until 4:00 p.m. CDT on Sept. 29 to submit their applications to the Louisiana Board of Pharmacy.
If the LSU Board of Supervisors approves LSU Health Shreveport’s plan on Sept. 8 for Louisiana medical marijuana research, perhaps the research will be ready to commence as soon as the program is operational in 2018.
As far as medical marijuana sales go, the future isn’t clear, but medical research could affect patient enrollment; according to LSU, “Sales of a medical marijuana product in 2018 could be as low as $727,000 and as high as $2.4 million. By 2024, sales could reach anywhere between $13.1 million and $20.1 million.”